BioLine RX Ltd Net Asset Momentum
BioLine RX Ltd net asset momentum. BioLine RX Ltd (BLRX) recorded a net asset momentum of 73.5% as of December 2025, with net assets of ILA23.35 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See BioLine RX Ltd shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of BioLine RX Ltd (2005–2025)
Net asset momentum of BioLine RX Ltd from 2005 to 2025. This chart tracks BioLine RX Ltd's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is +73.5%, with net assets of ILA23.35 Million ILA as of December 2025. Check BioLine RX Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
BioLine RX Ltd Net Asset Momentum by Year (2005–2025)
BioLine RX Ltd net asset momentum by year from 2005 to 2025. The table below shows the complete annual net asset history for BioLine RX Ltd from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see BioLine RX Ltd market capitalisation.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ILA23.35 Million | ILA40.91 Million | ILA17.56 Million | ▲ +73.5% |
| 2024 | ILA13.46 Million | ILA38.91 Million | ILA25.45 Million | ▲ +1.8% |
| 2023 | ILA13.22 Million | ILA63.92 Million | ILA50.70 Million | ▼ -74.0% |
| 2022 | ILA50.84 Million | ILA76.38 Million | ILA25.54 Million | ▼ -25.3% |
| 2021 | ILA68.09 Million | ILA81.39 Million | ILA13.30 Million | ▲ +209.1% |
| 2020 | ILA22.03 Million | ILA47.29 Million | ILA25.26 Million | ▼ -34.0% |
| 2019 | ILA33.38 Million | ILA53.57 Million | ILA20.19 Million | ▼ -19.2% |
| 2018 | ILA41.32 Million | ILA56.23 Million | ILA14.91 Million | ▼ -21.9% |
| 2017 | ILA52.88 Million | ILA60.97 Million | ILA8.08 Million | ▲ +51.0% |
| 2016 | ILA35.03 Million | ILA38.94 Million | ILA3.91 Million | ▼ -26.4% |
| 2015 | ILA47.61 Million | ILA51.30 Million | ILA3.69 Million | ▲ +49.9% |
| 2014 | ILA31.77 Million | ILA36.17 Million | ILA4.40 Million | ▲ +171.9% |
| 2013 | ILA11.68 Million | ILA19.95 Million | ILA8.27 Million | ▼ -22.0% |
| 2012 | ILA14.97 Million | ILA24.31 Million | ILA9.34 Million | ▼ -33.6% |
| 2011 | ILA22.53 Million | ILA29.34 Million | ILA6.81 Million | ▼ -82.9% |
| 2010 | ILA131.96 Million | ILA154.61 Million | ILA22.65 Million | ▲ +11.9% |
| 2009 | ILA117.94 Million | ILA159.17 Million | ILA41.23 Million | ▲ +50.5% |
| 2008 | ILA78.39 Million | ILA115.73 Million | ILA37.34 Million | ▼ -57.2% |
| 2007 | ILA183.25 Million | ILA207.88 Million | ILA24.63 Million | ▲ +14819.1% |
| 2006 | ILA-1.25 Million | ILA20.12 Million | ILA21.37 Million | ▼ -109.8% |
| 2005 | ILA12.77 Million | ILA20.59 Million | ILA7.83 Million | — |